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Routinely recorded coding data is increasingly being used for clinical research, but the quality of that 
data is often variable. The clinical coding of pleural empyema has not been studied. If data is not 
accurately recorded, linking coding data through, for example Hospital Episode Statistic data (HES) 
will lead to inappropriate conclusions.  
Methods: 
We extracted the coding data for a year from 3 hospitals in the South-West of England, UK: One a 
large district general hospital, one a tertiary pleural referral centre, and one a thoracic surgical 
centre. We verified and validated this coding to ensure its accuracy. To assess the sensitivity of 
coding, we then verified the coded cases against a cohort of proven empyema patients from a recent 
observational study. 
Results: 
182 patients with a coded diagnosis of pleural empyema were extracted. In 158 of these patients, 
the diagnosis was correct clinically, with a positive predictive value of 86%. In the cohort of 25 
patients with a known clinical diagnosis of empyema, 18 were coded as empyema, a sensitivity of 
72%. There was no significant difference in coding between hospitals. 
Conclusion: 
In the centres studied, empyema coding was generally good (>85% accuracy), although some cases 
were mis-coded. Using codes for elective admissions helped to differentiate post-operative from 
community acquired empyema. It is likely empyema is under rather than over-recorded in HES data. 
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Brief Report 
Introduction: 
Increasingly, research is performed on routinely recorded clinical data, such as hospital episode 
statistics (HES)1. In uncommon infectious diseases like pleural empyema, this data would be very 
useful in assessing trends in response to vaccination, or changes in microbiological epidemiology. 
Within the UK, empyema also has a significant healthcare tariff, and as such accurate recording is 
vital to ensure hospitals get appropriately reimbursed for care. 
HES data relies on accurate clinical coding, and empyema can pose a difficulty for clinical coders: 
requiring both a clinical, radiological, and microbiological elements to make a diagnosis. Additionally, 
a significant amount of empyema occurs post-surgery. Although this often meets the definition of 
empyema, it does not have the same microbiological, epidemiological, and demographics as 
‘community acquired’ empyema2.  
We aimed to assess the accuracy of coding for empyema across three separate trusts, one a district 
general hospital, one a tertiary pleural referral centre, and one a thoracic and upper gastrointestinal 
surgical centre. 
Methods: 
This was a retrospective, observational study, in two parts. In the first part, HES data was extracted 
for one year (August 2017 to August 2018) from the Royal United Hospital in Bath (Centre 1), the 
Bristol Royal Infirmary (Centre 2) and Southmead Hospital (Centre 3), both in Bristol (United 
Kingdom). These cases were verified to assess accuracy (see below). In the second part, data from 
participants in the Pleural Infection Longitudinal Outcome (PILOT) observational study of pleural 
empyema (for which Southmead Hospital was a recruitment centre between 2014 and 2016) was 
extracted. The coding of these known cases were cross checked with hospital coding data from the 
same period.  
The coded diagnoses of pleural empyema is defined as J86-, also known as pyothorax. The clinical 
diagnosis of empyema was made on retrospective review of the notes, discharge summary, 
radiology, and microbiology available. Empyema was considered as a pleural effusion that either had 
a documented pH of less than 7.2, microscopic evidence of infection, or frank pus. If microscopic 
evidence was not available, then clear clinical management as empyema (supporting radiology, 
clinical progress, biochemistry) were used.  
All cases were reviewed by an infectious disease physician, or a respiratory physician. 
Simple demographic data was collected, and the sensitivity and accuracy of coding for a clinical 
diagnosis were calculated. One of our aims was to differentiate empyema associated with 
community acquired infection from post-surgical empyema and we aimed to see if the approach of 
only identifying emergency admissions rather than elective admissions would be valuable. 
Results: 
Overall, 182 patients with a coded diagnosis of empyema were identified: 100 from Centre 2, and 49 
and 33 from Centres 1 and 3 respectively. This coding was accurate in 158 cases (86.8%). There were 
no significant differences coding accuracy between hospitals, despite the majority of patients in the 
surgical centres being transfers, rather than local patients. False positive rates were comparable  
across the three trusts: 16% at Centre 1, 10% at Centre 2, 18% at Centre 3 (p = 0.36 by x2). 
In the cohort of patients with a confirmed clinical diagnosis of empyema from the PILOT study, the 
coding was less accurate: of 25 patients, only 18 had the correct code at discharge, although one had 
no discharge summary, and one was transferred to the surgical centre. The sensitivity of coding was 
calculated as 72% (95% CI 51%-88%). The most common replacement code was ‘pleural effusion 
otherwise unspecified’. 
In the surgical centre, limiting the codes to exclude elective admissions slightly increased the 
accuracy of coding (from 90% to 93%). This coding also excluded the vast majority (14/21) of 
empyema secondary to cardiothoracic or upper GI surgery. 
Conclusion: 
Empyema coding was specific, with over 85% of discharge HES codes recorded accurately. However, 
in our prospectively collected cohort of patients known clinically to have empyema, 72% were coded 
as such, with the remainder having codes for an unclassified pleural effusion. Excluding codes for 
elective admission removed 2/3 of the post-surgical empyema, enabling more accurate identification 
of ‘community acquired empyema’. 
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